Prospects for diagnosis of prostate cancer by biomarkers in the urine.
- Author:
Yong LIU
1
;
Dong-Jin GENG
Author Information
1. Translational Science Laboratory, Drum Tower Hospital, Affiliated Hospital of Medical College, Nanjing University, Nanjing, Jiangsu 210008, China. mliuyong@hotmail.com
- Publication Type:Journal Article
- MeSH:
Biomarkers, Tumor;
urine;
Glutathione S-Transferase pi;
urine;
Humans;
Male;
Prostatic Neoplasms;
diagnosis;
Sensitivity and Specificity;
Thymosin;
urine
- From:
National Journal of Andrology
2006;12(5):453-455
- CountryChina
- Language:Chinese
-
Abstract:
Prostate cancer is the most frequently diagnosed cancer in the Western male population and the second leading cause of cancer mortality. Recently many new methods are used to detect the tumor, some of which use the urine as the sample. The biomarkers in the urine will possibly improve the sensitivity and specificity to aid in prostate cancer detection.
